Merck KGaA appoints Simon Sturge as new head of biosimilars unit
10:19 AM | February 20, 2014 | Deepti Ramesh
Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.